Nanotherapeutics Receives NIAID Contract as Part of a Multiple Award Pool for Task Orders Valued at Up to $159.4 Million

Company to Provide Advanced Biologics Manufacturing Services Under New, 10-Year Maximum Award

ALACHUA, FL, September 20, 2016 (BUSINESSWIRE) – Nanotherapeutics, Inc., a contract development and manufacturing organization (CDMO), announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the company a contract for advanced biologics manufacturing services as part of a multiple award IDIQ (Indefinite Delivery/Indefinite Quantity) pool. The contract has a maximum ceiling of $159.4 million and a performance period of up to 10 years.

Read the Full Article at BUSINESSWIRE

Share this post